Norris Perne & French LLP/Mi / TMO
Norris Perne & French LLP/Mi’s Thermo Fisher Scientific Inc Position
Does Norris Perne & French LLP/Mi own Thermo Fisher Scientific Inc (TMO)? Yes — 24.2K shares worth $12M (+0.80% of its 13F portfolio) as of Q1 2026, down from 26.0K shares the prior filed quarter.
Position Value
$12M
Q1 2026
Shares
24.2K
% of Portfolio
+0.80%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 24.2K | $12M | +0.80% |
| Q4 2025 | 26.0K | $15M | +0.99% |
| Q3 2025 | 26.4K | $13M | +0.89% |
| Q2 2025 | 26.4K | $11M | +0.75% |
| Q1 2025 | 25.4K | $13M | +0.95% |
| Q4 2024 | 35.8K | $19M | +1.34% |
| Q3 2024 | 35.8K | $22M | +1.52% |
| Q2 2024 | 36.1K | $20M | +1.44% |
| Q1 2024 | 35.8K | $21M | +1.49% |
| Q4 2023 | 36.8K | $20M | +1.51% |
| Q3 2023 | 25.8K | $13M | +1.14% |
| Q2 2023 | 25.6K | $13M | +1.12% |
| Q1 2023 | 24.7K | $14M | +1.31% |
| Q4 2022 | 24.8K | $14M | +1.35% |
| Q3 2022 | 25.5K | $13M | +1.34% |
| Q2 2022 | 25.3K | $14M | +1.32% |
| Q1 2022 | 25.0K | $15M | +1.19% |
| Q4 2021 | 24.9K | $17M | +1.29% |
| Q3 2021 | 25.8K | $15M | +1.27% |
| Q2 2021 | 25.5K | $13M | +1.11% |
| Q1 2021 | 33.8K | $15M | +1.43% |
| Q4 2020 | 40.0K | $19M | +1.76% |
| Q3 2020 | 40.1K | $18M | +1.92% |
| Q2 2020 | 40.2K | $15M | +1.77% |
| Q1 2020 | 40.1K | $11M | +1.71% |
| Q4 2019 | 54.4K | $18M | +2.11% |
| Q3 2019 | 54.1K | $16M | +1.97% |
| Q2 2019 | 55.8K | $16M | +2.07% |
| Q1 2019 | 55.4K | $15M | +2.00% |
| Q4 2018 | 56.4K | $13M | +1.97% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Norris Perne & French LLP/Mi’s full portfolio or all institutional holders of TMO.